Simplex Trading
PAVM icon

Simplex Trading’s PAVmed PAVM Stock Holding History

Simplex Trading’s Portfolio PAVM Stock Details PAVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-35
Closed -$231 – 9868
2025
Q4 		$231 Buy
35
+15
+75% +$171 ﹤0.01% 8245
2025
Q3 		$0 Buy
20
+1
+5% +$15 ﹤0.01% 9793
2025
Q2 		$0 Buy
19
+11
+138% +$220 ﹤0.01% 9464
2025
Q1 		$0 Buy
+8
New +$166 ﹤0.01% 9360
2024
Q2 		– Sell
-13
Closed -$648 – 9554
2024
Q1 		$0 Sell
13
-20
-61% -$1.51K ﹤0.01% 9596
2023
Q4 		$4K Sell
33
-8
-20% -$943 ﹤0.01% 7993
2023
Q3 		$5K Buy
41
+3
+8% +$465 ﹤0.01% 7675
2023
Q2 		$7K Buy
38
+21
+124% +$4.2K ﹤0.01% 7699
2023
Q1 		$2K Buy
17
+9
+113% +$1.89K ﹤0.01% 8503
2022
Q4 		$1K Sell
8
-11
-58% -$4.15K ﹤0.01% 8883
2022
Q3 		$7K Buy
19
+13
+217% +$7.37K ﹤0.01% 8552
2022
Q2 		$2K Sell
6
-15
-71% -$7.25K ﹤0.01% 9401
2022
Q1 		$12K Sell
21
-56
-73% -$41.6K ﹤0.01% 8741
2021
Q4 		$85K Buy
+77
New +$167K ﹤0.01% 6504
2021
Q2 		– Sell
-42
Closed -$99.2K – 10526
2021
Q1 		$84K Buy
+42
New +$63.2K ﹤0.01% 5979

Other funds holding PAVM

TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Simplex Trading's PAVM Position: Q1 2026 in Review

Simplex Trading sold out of PAVmed (PAVM) in Q1 2026, closing a stake of 35 shares — an estimated $231 sold.

Simplex Trading first reported a position in PAVM in Q1 2021 and held it in 15 quarters. The position peaked at $85K in Q4 2021. 20 funds tracked by Wall St. Rank hold PAVM as of Q1 2026.

  • Simplex Trading reported no remaining PAVmed position as of Q1 2026 after selling out during the quarter.
  • Simplex Trading sold 35 PAVmed shares in Q1 2026, an estimated $231.
  • Simplex Trading first reported a position in PAVmed in Q1 2021 and held it in 15 quarters.
  • Simplex Trading's PAVmed position peaked at $85K in Q4 2021.
  • 20 funds tracked by Wall St. Rank held PAVmed as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.